FNB
REGN icon

Farmers National Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Farmers National Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$4K Sell
13
-16
-55% -$5.33K ﹤0.01% 281
2019
Q1 		$12K Buy
+29
New +$11.9K 0.01% 263

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Farmers National Bank's REGN Position: Q2 2019 in Review

Farmers National Bank reduced its Regeneron Pharmaceuticals (REGN) stake by 55% in Q2 2019, selling an estimated $5.33K and leaving 13 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #281.

Farmers National Bank first reported a position in REGN in Q1 2019 and has held it in 2 quarters since. The position peaked at $12K in Q1 2019. 658 funds tracked by Wall St. Rank hold REGN as of Q2 2019.

  • Farmers National Bank held 13 shares of Regeneron Pharmaceuticals worth $4K as of Q2 2019.
  • Farmers National Bank sold 16 Regeneron Pharmaceuticals shares in Q2 2019, an estimated $5.33K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Farmers National Bank's portfolio in Q2 2019, its #281 holding.
  • Farmers National Bank first reported a position in Regeneron Pharmaceuticals in Q1 2019 and has held it in 2 quarters since.
  • Farmers National Bank's Regeneron Pharmaceuticals position peaked at $12K in Q1 2019.
  • 658 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2019.

Based on Farmers National Bank's 13F filing for Q2 2019, filed 22 Aug 2019.